🇰🇷 GRAPIPRANT in South Korea

GRAPIPRANT (GRAPIPRANT) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

GRAPIPRANT in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in South Korea

Frequently asked questions

Is GRAPIPRANT approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for GRAPIPRANT in South Korea?

Marketing authorisation holder not available in our data.